Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy.

ABSTRACT: Standard-of-care treatment regimens have long been designed for maximal cell killing, yet these strategies often fail when applied to metastatic cancers due to the emergence of drug resistance. Adaptive treatment strategies have been developed as an alternative approach, dynamically adjusting treatment to suppress the growth of treatment-resistant populations and thereby delay, or even prevent, tumor progression. Promising clinical results in prostate cancer indicate the potential to optimize adaptive treatment protocols. Here, we applied deep reinforcement learning (DRL) to guide adaptive drug scheduling and demonstrated that these treatment schedules can outperform the current adaptive protocols in a mathematical model calibrated to prostate cancer dynamics, more than doubling the time t

SUBMITTER: Gallagher K 

PROVIDER: S-EPMC11148552 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature